Impact of antibody aggregation on a flowthrough anion-exchange membrane process

Biotechnology Progress

Volumn 26, Issue 6, 2010, Pages 1654-1661

  Lajmi, Ajay R ^a   Nochumson, Samuel ^a   Berges, Aym ^b  

^a Biopurification Laboratory of Pall Life Sciences   (United States)

^b Wyatt Technology Corporation   (United States)

Author keywords

Anion exchange chromatography; Antibody aggregation; Antibody purification; Light scattering; Membrane chromatography; Membrane fouling

Indexed keywords

ANION EXCHANGE; ANION EXCHANGE CHROMATOGRAPHY; ANION EXCHANGE MEMBRANE; ANTIBODY AGGREGATION; ANTIBODY PURIFICATION; BLOCKING MODELS; CAKE FILTRATION; FILTRATION AREA; FLOWTHROUGH; IN-LINE; MASS LOADINGS; MEMBRANE CHROMATOGRAPHY; MEMBRANE PORES; MULTIANGLE LASER LIGHT SCATTERING; POLYETHERSULFONES; POLYVINYLIDENE FLUORIDE MEMBRANES; PREFILTERS; SCALE-DOWN; THROUGHPUT PERFORMANCE;

ANTIBODIES; IONS; LIGHT SCATTERING; MEMBRANE FOULING; MEMBRANES; PURIFICATION; REFRACTION; SCATTERING; SIZE EXCLUSION CHROMATOGRAPHY; THROUGHPUT;

MICROFILTRATION;

ANION; IMMUNOGLOBULIN G;

ARTICLE; ARTIFICIAL MEMBRANE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; LASER; PARTICLE SIZE; RADIATION SCATTERING; SURFACE PROPERTY;

ANIONS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; IMMUNOGLOBULIN G; LASERS; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; SCATTERING, RADIATION; SURFACE PROPERTIES;

EID: 78650204026     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.483     Document Type: Article

References (20)

1. Ahrer K, Buchacher A, Iberer G, Jungbauer A. Detection of aggregate formation during production of human immunoglobulin G by means of light scattering. J Chromatogr A. 2004; 1043: 41-46.
2. Bolton G, LaCasse D, Kuriyel R. Combined models of membrane fouling: development and application to microfiltration and ultrafiltration of biological fluids. J Membr Sci. 2006; 277: 75-84.
3. Braun A, Kwee MA, Labow J, Alsenz J. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha in normal and transgenic mice. Pharm Res. 1997; 14: 1472-1478.
4. Fahrner RL, Knudsen HL, Basey CD, Galan W, Feuerhelm D, Vanderlaan M, Blank GS. Industrial purification of pharmaceutical antibodies: development, operation and validation of chromatography processes. Biotechnol Gen Eng Rev. 200l; 18: 301-327.
5. Gebauer KH, Thommes J, Kula MR. Plasma protein fractionation with advanced membrane adsorbents. Biotechnol Bioeng. 1997; 54: 181-189.
6. Hermeling S, Aranha L, Damen JM, Slijper M, Schellekens H, Crommelin DJ, Jiskoot W. Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha 2b. Pharm Res. 2005; 22: 1997-2006.
7. Knudsen HL, Fahrner RL, Xu Y, Norling LA, Blank GS. Membrane ion-exchange chromatography for process-scale antibody purification. J Chromatogr A. 2001; 907: 145-154.
8. Lajmi AR, Kutner R, Reiser J. A membrane chromatography application: a rapid, high capacity gene therapy vector purification tool. In: Shukla AA, Etzel M, Gadam S, editors. Process Scale Bioseparations for the Biopharmaceutical Industry. Boca Raton: Taylor Francis; 2006: 541-564.
9. Low D, O'Leary R, Pujar NS. Future of antibody purification. J Chromatogr B. 2007; 848: 48-63.
10. Lutz H, Abbott I, Blanchard M, Parampalli A, Setiabudi G, Chiruvolu V, Noguchi M. Considerations for scaling-up depth filtration of harvested cell culture fluid. Biopharm Int. 2009; 22: 58-66.
11. Palacio L, Ho CC, Zydney AL. Application of a pore-blockage cake-filtration model to protein fouling during microfiltration. Biotechnol Bioeng. 2002; 79: 260-270.
12. Riordan W, Heilmann S, Brorson K, Kannan S, He Y, Etzel M. Design of salt tolerant membrane adsorbers for viral clearance. Biotechnol Bioeng. 2009; 103: 920-929.
13. Szenczi A, Kardos J, Medgyesi GA, Zavodszky P. The effect of solvent environment on the conformation stability of human polyclonal IgG in solution. Biologicals. 2006; 34: 5-14.
14. Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies-application of platform approaches. J Chromatogr B. 2007; 848: 28-39.
15. Specht R, Han B, Wickramasinghe SR, Carlson JO, Czermak P, Wolf A, Reif OW. Densonucleosis virus. Biotechnol Bioeng. 2004; 88: 465-473.
16. Strauss DM, Gorrell J, Plancarte M, Blank GS, Chen Q, Yang B. Anion exchange chromatography provides a robust, predictable process to ensure viral safety of biotechnology products. Biotechnol Bioeng. 2009; 102: 168-175.
17. van Reis R, Zydney A. Bioprocess membrane technology. J Membr Sci. 2007; 297: 16-50.
18. Zhang S, Krivosheyeva A, Nochumson S. Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules. Biotechnol Appl Biochem. 2003; 37: 245-249.
19. Zhou JX, Tressel T. Basic concepts in Q membrane chromatography for large scale antibody production. Biotechnol Prog. 2006; 22: 341-349.
20. Zhou JX, Tressel T, Gottschalk U, Solamo F, Pastor A, Dermawan S, Hong T, Reif O, Mora J, Hutchison F, Murphy M. New Q membrane scale-down model for process-scale antibody purification. J Chromatogr A. 2006; 1134: 66-73.